Virtus LifeSci Biotech Clinical Trials ETF
12 hedge funds and large institutions have $9.17M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
CCP
1
Cardan Capital Partners
Denver,
Colorado
|
$0 |
| 2 |
2
Goldman Sachs
New York
|
$2.9M |
| 3 |
AWM
3
Avior Wealth Management
Omaha,
Nebraska
|
$0 |
| 4 |
4
LPL Financial
San Diego,
California
|
$924K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ASN
1
Advisory Services Network
Atlanta,
Georgia
| $3.08M | 108,357 | +21,118 | +24% |
|
|
2
Goldman Sachs
New York
| $2.9M | 101,888 | -8,534 | -8% |
|
3
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1.28M | 44,940 | +17,037 | +61% |
|
|
4
LPL Financial
San Diego,
California
| $924K | 32,491 | -496 | -2% |
|
5
Jane Street
New York
| $685K | 24,086 | +24,086 | New |
|
|
LTFS
6
Ladenburg Thalmann Financial Services
Miami,
Florida
| $128K | 4,500 | +1,500 | +50% |
|
|
CA
7
Calton & Associates
Tampa,
Florida
| $74K | 2,239 | +2,239 | New |
|
8
Morgan Stanley
New York
| $40K | 1,400 | – | – |
|
9
Wells Fargo
San Francisco,
California
| $21K | 729 | – | – |
|
10
UBS Group
Zurich,
Switzerland
| $20K | 716 | +716 | New |
|
|
MPWT
11
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $15.2K | 533 | +110 | +26% |
|
12
Envestnet Asset Management
Chicago,
Illinois
| $10K | 338 | +338 | New |
|
|
CCP
13
Cardan Capital Partners
Denver,
Colorado
| – | – | -23,541 | Closed |
|
|
AWM
14
Avior Wealth Management
Omaha,
Nebraska
| – | – | -500 | Closed |
|